• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人蛋白酶激活受体4的克隆与特性分析

Cloning and characterization of human protease-activated receptor 4.

作者信息

Xu W F, Andersen H, Whitmore T E, Presnell S R, Yee D P, Ching A, Gilbert T, Davie E W, Foster D C

机构信息

Department of Biochemistry, University of Washington, Box 357350, Seattle, WA 98195-7350, USA.

出版信息

Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6642-6. doi: 10.1073/pnas.95.12.6642.

DOI:10.1073/pnas.95.12.6642
PMID:9618465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC22580/
Abstract

Protease-activated receptors 1-3 (PAR1, PAR2, and PAR3) are members of a unique G protein-coupled receptor family. They are characterized by a tethered peptide ligand at the extracellular amino terminus that is generated by minor proteolysis. A partial cDNA sequence of a fourth member of this family (PAR4) was identified in an expressed sequence tag database, and the full-length cDNA clone has been isolated from a lymphoma Daudi cell cDNA library. The ORF codes for a seven transmembrane domain protein of 385 amino acids with 33% amino acid sequence identity with PAR1, PAR2, and PAR3. A putative protease cleavage site (Arg-47/Gly-48) was identified within the extracellular amino terminus. COS cells transiently transfected with PAR4 resulted in the formation of intracellular inositol triphosphate when treated with either thrombin or trypsin. A PAR4 mutant in which the Arg-47 was replaced with Ala did not respond to thrombin or trypsin. A hexapeptide (GYPGQV) representing the newly exposed tethered ligand from the amino terminus of PAR4 after proteolysis by thrombin activated COS cells transfected with either wild-type or the mutant PAR4. Northern blot showed that PAR4 mRNA was expressed in a number of human tissues, with high levels being present in lung, pancreas, thyroid, testis, and small intestine. By fluorescence in situ hybridization, the human PAR4 gene was mapped to chromosome 19p12.

摘要

蛋白酶激活受体1 - 3(PAR1、PAR2和PAR3)是独特的G蛋白偶联受体家族的成员。它们的特征是在细胞外氨基末端有一个通过轻微蛋白水解产生的拴系肽配体。在一个表达序列标签数据库中鉴定出了该家族第四个成员(PAR4)的部分cDNA序列,并从淋巴瘤Daudi细胞cDNA文库中分离出了全长cDNA克隆。该开放阅读框编码一个由385个氨基酸组成的七跨膜结构域蛋白,与PAR1、PAR2和PAR3具有33%的氨基酸序列同一性。在细胞外氨基末端鉴定出一个假定的蛋白酶切割位点(Arg - 47/Gly - 48)。用PAR4瞬时转染的COS细胞在用凝血酶或胰蛋白酶处理时会导致细胞内三磷酸肌醇的形成。将Arg - 47替换为Ala的PAR4突变体对凝血酶或胰蛋白酶无反应。一种代表PAR4氨基末端经凝血酶蛋白水解后新暴露的拴系配体的六肽(GYPGQV)激活了用野生型或突变型PAR4转染的COS细胞。Northern印迹显示PAR4 mRNA在多种人类组织中表达,在肺、胰腺、甲状腺、睾丸和小肠中含量较高。通过荧光原位杂交,将人类PAR4基因定位于19号染色体p12区域。

相似文献

1
Cloning and characterization of human protease-activated receptor 4.人蛋白酶激活受体4的克隆与特性分析
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6642-6. doi: 10.1073/pnas.95.12.6642.
2
Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.中性粒细胞蛋白酶可使人类PAR3失活,并消除PAR3在小鼠血小板上的共受体功能。
Thromb Haemost. 2001 Mar;85(3):533-8.
3
Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.重组蛋白酶激活受体胞外域的蛋白水解作用:通过基质辅助激光解吸电离质谱法预测受体激活或失活
Biochemistry. 2000 Sep 5;39(35):10812-22. doi: 10.1021/bi0003341.
4
Protease-activated receptor 1 (PAR1) and PAR4 heterodimers are required for PAR1-enhanced cleavage of PAR4 by α-thrombin.蛋白酶激活受体 1(PAR1)和 PAR4 异二聚体是 α-凝血酶增强 PAR4 裂解所必需的。
J Biol Chem. 2013 Nov 8;288(45):32553-32562. doi: 10.1074/jbc.M113.472373. Epub 2013 Oct 4.
5
Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.胰蛋白酶通过蛋白酶激活受体-2诱导人嗜酸性粒细胞的活化和炎症介质释放。
J Immunol. 2001 Dec 1;167(11):6615-22. doi: 10.4049/jimmunol.167.11.6615.
6
Conserved structure and adjacent location of the thrombin receptor and protease-activated receptor 2 genes define a protease-activated receptor gene cluster.凝血酶受体和蛋白酶激活受体2基因的保守结构及相邻位置定义了一个蛋白酶激活受体基因簇。
Mol Med. 1996 May;2(3):349-57.
7
Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.炎症介质通过诱导蛋白酶激活受体-4的表达来调节人支气管成纤维细胞中的凝血酶和组织蛋白酶G信号传导。
Am J Physiol Lung Cell Mol Physiol. 2007 Mar;292(3):L788-98. doi: 10.1152/ajplung.00226.2006. Epub 2006 Dec 1.
8
Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1.人内皮细胞中的凝血酶反应。除PAR1之外的受体的作用包括凝血酶切割的PAR1对PAR2的反式激活。
J Biol Chem. 2000 May 5;275(18):13502-9. doi: 10.1074/jbc.275.18.13502.
9
Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage.蛋白酶激活受体-4利用双脯氨酸和一个阴离子保留基序来识别和裂解凝血酶。
Biochem J. 2003 Dec 15;376(Pt 3):733-40. doi: 10.1042/BJ20030954.
10
Neutrophil cathepsin G proteolysis of protease-activated receptor 4 generates a novel, functional tethered ligand.中性粒细胞组织蛋白酶 G 对蛋白酶激活受体 4 的蛋白水解作用产生了一种新型的、有功能的连接配体。
Blood Adv. 2022 Apr 12;6(7):2303-2308. doi: 10.1182/bloodadvances.2021006133.

引用本文的文献

1
From theory to platelets: unraveling the history and complexities of biased signaling.从理论到血小板:揭示偏向性信号传导的历史与复杂性
Blood Vessel Thromb Hemost. 2025 May 5;2(3):100073. doi: 10.1016/j.bvth.2025.100073. eCollection 2025 Aug.
2
Selective Modulation of PAR-2-Driven Inflammatory Pathways by Oleocanthal: Attenuation of TNF-α and Calcium Dysregulation in Colorectal Cancer Models.橄榄苦苷对PAR-2驱动的炎症途径的选择性调节:在结直肠癌模型中减轻肿瘤坏死因子-α和钙失调
Int J Mol Sci. 2025 Mar 24;26(7):2934. doi: 10.3390/ijms26072934.
3
Endothelial protease-activated receptor 4: impotent or important?内皮蛋白酶激活受体4:无作用还是重要?
Front Cardiovasc Med. 2025 Jan 28;12:1541879. doi: 10.3389/fcvm.2025.1541879. eCollection 2025.
4
Coagulation protease-induced extracellular vesicles: their potential effects on coagulation and inflammation.凝血蛋白酶诱导的细胞外囊泡:它们对凝血和炎症的潜在影响。
J Thromb Haemost. 2024 Nov;22(11):2976-2990. doi: 10.1016/j.jtha.2024.07.022. Epub 2024 Aug 8.
5
Structural basis of tethered agonism and G protein coupling of protease-activated receptors.蛋白酶激活受体的束缚激动和 G 蛋白偶联的结构基础。
Cell Res. 2024 Oct;34(10):725-734. doi: 10.1038/s41422-024-00997-2. Epub 2024 Jul 12.
6
Elevated protease-activated receptor 4 (PAR4) gene expression in Alzheimer's disease predicts cognitive decline.阿尔茨海默病中蛋白酶激活受体 4 (PAR4) 基因表达升高预示认知能力下降。
Neurobiol Aging. 2024 Aug;140:93-101. doi: 10.1016/j.neurobiolaging.2024.04.007. Epub 2024 Apr 21.
7
Coagulation Protease-Driven Cancer Immune Evasion: Potential Targets for Cancer Immunotherapy.凝血蛋白酶驱动的癌症免疫逃逸:癌症免疫治疗的潜在靶点
Cancers (Basel). 2024 Apr 19;16(8):1568. doi: 10.3390/cancers16081568.
8
A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity.蛋白酶激活受体4 Pro310Leu变体的小鼠模型血小板反应性降低。
J Thromb Haemost. 2024 Jun;22(6):1715-1726. doi: 10.1016/j.jtha.2024.03.004. Epub 2024 Mar 19.
9
Coagulation Factor Xa Has No Effects on the Expression of PAR1, PAR2, and PAR4 and No Proinflammatory Effects on HL-1 Cells.凝血因子Xa对PAR1、PAR2和PAR4的表达无影响,对HL-1细胞无促炎作用。
Cells. 2023 Dec 15;12(24):2849. doi: 10.3390/cells12242849.
10
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy.抗凝治疗对恶性肿瘤患者的抗炎和抗癌作用
Life (Basel). 2023 Sep 10;13(9):1888. doi: 10.3390/life13091888.

本文引用的文献

1
Endothelial cell thrombin receptors and PAR-2. Two protease-activated receptors located in a single cellular environment.内皮细胞凝血酶受体与PAR-2。两种位于单一细胞环境中的蛋白酶激活受体。
J Biol Chem. 1997 Apr 25;272(17):11133-41. doi: 10.1074/jbc.272.17.11133.
2
Protease-activated receptor 3 is a second thrombin receptor in humans.蛋白酶激活受体3是人类的第二种凝血酶受体。
Nature. 1997 Apr 3;386(6624):502-6. doi: 10.1038/386502a0.
3
The PROSITE database, its status in 1997.PROSITE数据库及其1997年的状况。
Nucleic Acids Res. 1997 Jan 1;25(1):217-21. doi: 10.1093/nar/25.1.217.
4
Conserved structure and adjacent location of the thrombin receptor and protease-activated receptor 2 genes define a protease-activated receptor gene cluster.凝血酶受体和蛋白酶激活受体2基因的保守结构及相邻位置定义了一个蛋白酶激活受体基因簇。
Mol Med. 1996 May;2(3):349-57.
5
Role of the thrombin receptor in development and evidence for a second receptor.凝血酶受体在发育中的作用及第二种受体的证据。
Nature. 1996 Jun 6;381(6582):516-9. doi: 10.1038/381516a0.
6
Thrombin receptor activating mutations. Alteration of an extracellular agonist recognition domain causes constitutive signaling.凝血酶受体激活突变。细胞外激动剂识别域的改变导致组成性信号传导。
J Biol Chem. 1996 Jan 12;271(2):702-6. doi: 10.1074/jbc.271.2.702.
7
Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses.活化蛋白C与人单核吞噬细胞上的特定受体结合,可抑制细胞内钙信号传导及单核细胞依赖性增殖反应。
Transplantation. 1995 Dec 27;60(12):1525-32. doi: 10.1097/00007890-199560120-00026.
8
Human plasmin induces a receptor-mediated arachidonate release coupled with G proteins in endothelial cells.人纤溶酶在内皮细胞中诱导一种与G蛋白偶联的受体介导的花生四烯酸释放。
Am J Physiol. 1993 Feb;264(2 Pt 1):C271-81. doi: 10.1152/ajpcell.1993.264.2.C271.
9
Cathepsin G and thrombin: evidence for two different platelet receptors.组织蛋白酶G和凝血酶:两种不同血小板受体的证据。
Biochem J. 1994 Jan 15;297 ( Pt 2)(Pt 2):269-75. doi: 10.1042/bj2970269.
10
Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases.G蛋白偶联受体激酶对凝血酶受体信号传导的抑制作用。G蛋白偶联受体激酶之间的功能特异性。
J Biol Chem. 1994 Jan 14;269(2):1125-30.